Importance Estimating the current likelihood of transitioning from a clinical high risk for
psychosis (CHR-P) to psychosis holds paramount importance for preventive care and …

Context A substantial proportion of people at clinical high risk of psychosis will develop a
psychotic disorder over time. However, the risk of transition to psychosis varies between …

Aims The clinical outcomes of individuals at clinical high risk of psychosis (CHR-P) who do
not transition to psychosis are heterogeneous and inconsistently reported. We aimed to …

Diagnosis of a clinical high-risk (CHR) state enables timely treatment of individuals at risk for
a psychotic disorder, thereby contributing to improving illness outcomes. However, only a …

Meta-analytic evidence indicates that baseline exposure to antipsychotics (AP) in individuals
at clinical high-risk for psychosis (CHR-P) is associated with an even higher risk of transition …

Twenty percent of individuals at clinical high risk for psychosis (CHR-P) develop the disorder
within 2 years. Extensive research has explored the factors that differentiate those who …

Importance Detection, prognosis, and indicated interventions in individuals at clinical high
risk for psychosis (CHR-P) are key components of preventive psychiatry. Objective To …

Recent evidence suggests that transition risks from initial clinical high risk (CHR) status to
psychosis are decreasing. The role played by remission in this context is mostly unknown …

BackgroundTo enhance indicated prevention in patients with a clinical high risk (CHR) for
psychosis, recent research efforts have been increasingly directed towards estimating the …

Accurate prognostication of individuals at clinical high-risk for psychosis (CHR-P) is an
essential initial step for effective primary indicated prevention. We aimed to summarise the …